Esophageal motion during radiotherapy: Quantification and margin implications

Diseases of the Esophagus

Volumn 23, Issue 6, 2010, Pages 473-479

  Cohen, R J ^a   Paskalev, K ^a   Litwin, S ^a   Price Jr , R A ^a   Feigenberg, S J ^b   Konski, A A ^c  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Esophageal cancer; Organ motion; Radiotherapy; Treatment margin

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTERIOR POSTERIOR AXIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS MOTILITY; FEMALE; HUMAN; IMAGE ANALYSIS; INTENSITY MODULATED RADIATION THERAPY; MALE; PATIENT CARE PLANNING; PRIORITY JOURNAL; SIMULATION;

ADULT; AGED; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 77955940086     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.01037.x     Document Type: Article

References (22)

1. Herskovic A, Martz K, al-Sarraf M. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992, 326:1593-8.
2. Macdonald J S, Smalley S R, Benedetti J. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001, 345:725-30.
3. Minsky B D, Pajak T F, Ginsberg R J. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002, 20:1167-74.
4. Tepper J, Krasna M J, Niedzwiecki D. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008, 26:1086-92.
5. Walsh T N, Noonan N, Hollywood D. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996, 335:462-7.
6. Lee H K, Vaporciyan A A, Cox J D. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 2003, 57:1317-22.
7. Tucker S L, Liu H H, Wang S. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2006, 66:754-61.
8. Martel M K, Sahijdak W M, Ten Haken R K. Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys 1998, 40:155-61.
9. Konski A A, Li T, Cohen S J. The effect of gender and dose on the development of symptomatic cardiac toxicity after chemoradiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 2008, 72:S254. abstract
10. Welch R W, Gray J E. Influence of respiration on recordings of lower esophageal sphincter pressure in humans. Gastroenterology 1982, 83:590-4.
11. Good E, Oral H, Lemola K. Movement of the esophagus during left atrial catheter ablation for atrial fibrillation. J Am Coll Cardiol 2005, 46:2107-10.
12. Pan C C, Kashani R, Hayman J A. Intra- and inter-fraction esophagus motion in 3D-conformal radiotherapy: implications for ICRU 62 definitions of internal target volume and planning organ at risk volume. Int J Radiat Oncol Biol Phys 2004, 60:S580-1. abstract
13. Lorchel F, Dumas J L, Noel A. Esophageal cancer: determination of internal target volume for conformal radiotherapy. Radiother Oncol 2006, 80:327-32.
14. Guerrero T, Zhang G, Huang T C. Intrathoracic tumour motion estimation from CT imaging using the 3D optical flow method. Phys Med Biol 2004, 49:4147-61.
15. Dieleman E M, Senan S, Vincent A. Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. Int J Radiat Oncol Biol Phys 2007, 67:775-80.
16. Patel A A, Wolfgang J A, Niemierko A. Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer. Int J Radiat Oncol Biol Phys 2009, 74:290-6.
17. Sasidharan S, Allison R, Jenkins T. Interfraction esophagus motion study in image guided radiation therapy (IGRT). Int J Radiat Oncol Biol Phys 2005, 63:S91-2. abstract
18. Ma C M, Paskalev K. In-room CT techniques for image-guided radiation therapy. Med Dosim 2006, 31:30-9.
19. Kendall M G, Stuart A, Ord J K. Kendall's Advanced Theory of Statistics 1994, 6th, edn., New York, Halsted Press
20. Greene F L. AJCC Cancer Staging Handbook: from the AJCC Cancer Staging Manual 2002, American Joint Committee on Cancer, American Cancer Society, 6th, edn., New York, Springer
21. Yaremko B P, Guerrero T M, McAleer M F. Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 2008, 70:145-53.
22. Zhao K L, Liao Z, Bucci M K. Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiother Oncol 2007, 84:283-9.